Table 2.
Logistic regression analyses of components in IGFs/IGF-IR system in relation to the sensitivity to IGF-IR inhibitor BMS-536924
Gene | P | Odds ratio* (95% CI) | AUC |
---|---|---|---|
IGF-I | 0.039 | 2.86 (0.08–0.96) | 0.67 |
IGF-II | 0.062 | 2.27 (0.13–1.04) | 0.63 |
IGF-I + IGF-II | 0.0004 | 4.76 (0.07–0.62) | 0.87 |
IGF-IR | 0.011 | 3.45 (0.07–0.78) | 0.8 |
IGFBP-3 | 0.006 | 0.27 (1.39–14.58) | 0.75 |
IGFBP-6 | 6.79E–06 | 0.07 (3.45–150.88) | 0.91 |
Insulin | 0.556 | 1.26 (0.58–2.98) | 0.53 |
IR | 0.1094 | 1.94 (0.87–5.08) | 0.75 |
Abbreviations: 95% CI, 95% confidence interval; AUC, area under the receiver operating characteristic curve; IR, insulin receptor.
For odds of BMS-536924–sensitive versus resistant cell line groups, as defined in Table 1.